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A/H1N1 flu pANdemic
History and economics lessons 
in asymmetrical flu threats
The process of combining predictive tools in 
epidemiology and biostatistics with those from 
history and economics to develop a sustainable 
framework for addressing the ongoing swine flu 
pandemic is a global multidisciplinary challenge. 
During the 1976 swine flu outbreak, a precipitate 
decision to produce and initiate mass vaccination 
led to more vaccine-related morbidity and 
mortality than swine flu infections, adversely 
affecting public health’s credibility. The current 
outbreak is so far mild compared 
with seasonal flu in the southern 
hemisphere. Therefore, whether 
vaccination should be the global 
first line of defence, as recently 
suggested by the World Health 
Organization, or whether current 
chemotherapeutic approaches are 
safer and more cost effective should 
be reconsidered.1 2
The contingency plans of the 
current swine flu pandemic seem 
to parallel the international sanitary 
conferences for cholera control in the mid-19th 
century. Then, most of the planning focused on 
protecting wealthy European nations from cholera, 
while nations in cholera’s epicentre, particularly 
those adjacent to the Bay of Bengal, were under-
represented.3 Now, Australia’s investment of 
over $480m (£294m; €336) in pandemic flu 
preparedness over the past three years exceeds 
the national flu control budgets of Mexico and 
all African countries.4 The United States spent 
$135m in procuring 48 million vaccine doses 
for swine flu in 1976. The current cost of antiviral 
chemotherapy for swine flu is at least $50 for each 
five day course. Healthcare workers are expected 
to take prophylactic antiviral drugs for up to six 
weeks while caring for patients with swine flu.5
Any plans yet for how these laudable initiatives 
will be funded in poor countries?
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Antiviral drugs: distinguish 
treatment from prophylaxis
Shun-Shin and colleagues provide a timely 
review of the effectiveness of neuraminidase 
inhibitors for treatment and chemoprophylaxis 
of flu virus infections.1 As the pandemic A/
H1N1 flu virus seems to have 
remained susceptible in vitro to 
neuraminidase inhibitors we expect 
that effectiveness against the 
pandemic virus would be similar 
to that against seasonal influenza 
A strains. There should by now be 
sufficient observational data to 
demonstrate this. Further trials to 
detect differences in effectiveness 
between pandemic and seasonal 
strains would need to be very large.
Distinguishing the use of 
antiviral drugs for treatment from their use as 
chemoprophylaxis against infection or illness is 
important. In the current pandemic oseltamivir 
treatment has been widely used in many countries 
as part of “mitigation phase” protocols whereas 
chemoprophylaxis has rarely been used since 
the initial “containment phase.” Shun-Shin 
and colleagues’ conclusion that neuraminidase 
inhibitors shorten the duration of illness and 
reduce household transmission does not clarify 
that transmission refers to chemoprophylaxis 
whereas duration refers to treatment, as 
the review did not cover indirect benefits of 
treatment.1 Oseltamivir treatment alone may 
lead to moderate reductions in transmission to 
household contacts.2
The 8% reduction in household transmission 
associated with chemoprophylaxis is an estimate 
of the absolute risk reduction, from around 12% 
in the placebo arm to around 4% in the antiviral 
arm,1 corresponding to a relative risk reduction of 
almost 70%. However, in pandemics, secondary 
attack rates are typically higher because of the 
lack of population immunity,3 and absolute risk 
reductions associated with chemoprophylaxis 
may be greater.
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cow’s milk Allergy iN cHildreN
Challenge is not crucial
Apps and Beattie state that diagnosis of cow’s 
milk allergy should be confirmed by challenge, 
even in those at risk of severe reactions.1 In 
practice, such confirmation is rarely done as it 
can be dangerous, is resource consuming, and is 
often unnecessary with a good history, positive 
test results (skin prick or specific IgE), and 
improvement with elimination of cow’s milk.2 
Oral challenge should be reserved for cases 
with large diagnostic doubt, and for determining 
whether a known food allergy has resolved.
The authors incorrectly imply a significant 
difference in positive predictive value between 
specific IgE and skin prick testing. A positive 
specific IgE test does not have a positive 
predictive value as high as 90-95%. Specific IgE 
value may be important. A positive predictive 
value of 90% refers to specific IgE >2.5 kU(A)/l in 
infants under 12 months.3 The threshold varies 
in different studies: a threshold for milk of 15 
kU(A)/l in children with a mean age of 5 years 
predicted clinical reactivity with >95% certainty.4 
Similar studies assess the size of a wheal in 
skin prick testing above which 95% of patients 
would have an allergic reaction to that food.
Conversely, allergy to cow’s milk is possible 
with a low or even negative specific IgE or skin 
prick testing result.
Non-IgE mediated milk allergy is not 
necessarily a type IV hypersensitivity reaction: 
the exact immunopathophysiology is unknown.2
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BmJ pico
pico research for  
pico doctors
Rapid responses in many cases resemble radio 
phone-ins, where people take up time without 
having anything much to say. In the rare instance 
when they do have something to say, I suspect 
that the people in a position to change things 
don’t take any notice.
BMJ pico is pico minded.1 As in bite size 
education, pico size education is for pico size 
brains. One can see the slogans now: Read BMJ 
on the go! Pico—all you need to know in just a 
few minutes!
Why stop at pico? Be bold BMJ! In a few years 
when BMJ pico becomes the norm for research, 
go for nano—a quarter of a page. When nano is 
too much of a burden to read, go for femto—just 
one liners. Preferably on Twitter. And why not 
team up with O2 and send the one liners by 
mobile phone?
Pico editors for a generation of pico doctors—
with femto and nano to look forward to.
I would prefer splitting the BMJ in two: Pico 
BMJ and Normal BMJ. Pico BMJ has all the 
infotainment and could also include fashion, 
financial advice, secondhand cars, lonely hearts, 
recipes, travel, etc. Normal BMJ has the format 
used by highly read and highly rated medical 
journals such as JAMA and the Lancet.
Some doctors may prefer to subscribe only to 
Pico BMJ, some only to Normal BMJ, and some 
to both. The BMJ would most likely increase its 
overall subscription rates: those who do not 
currently subscribe (pico doctors who may be 
put off by seeing 3-5 pages of research papers 
and normal doctors who are put off by the 
infotainment) might well subscribe. Initially 
the two journals will have to share editors and 
peer reviewers but as they diverge, editors 
and reviewers will be different to cater for their 
different readership.
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understanding what  
you read
Groves and Schroter say that BMJ pico articles 
will be accompanied by a table showing ratio 
measures (relative risk, odds ratio).1 However, 
evidence consistently shows that even 
experienced professionals may fail to interpret 
correctly data reported as ratio measures,2 
which may in turn affect decision making and 
communication with patients.3 Better ways of 
conveying information are being developed,4 5 and 
the BMJ should not miss the opportunity to apply 
them if the pico articles are to fulfil their potential.
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tHe AmericAN crisis
America’s failure to provide
My father was a young general practitioner in 
Portsmouth at the inception of the NHS in 1948 
and proud of being able to look after his poor 
patients living in the slums.1
I provide federally funded medical care to 
a few of the 46 million uninsured Americans: 
the working poor, homeless mentally ill, recent 
immigrants and migrant workers, and senior 
citizens with inadequate cover for their needs. 
I have a very hard time obtaining the services 
they need outside my own primary care efforts. 
They must scrabble for cash (which they 
seldom get) to pay for medicine, consultant 
evaluations, optometry, and dental services; 
there is no domiciliary care; and hospitals kick 
them out in the middle of the night if they are 
able to walk.
I am currently in England looking after my 
dying mother at home. Nurses come in four 
times a day, the general practitioner visits three 
times a week, physiotherapy and occupational 
therapy are provided, and a night nurse comes 
every other night while I get some sleep. All 
medicine and supplies, including a hospital 
bed, are free. Staff have also gone out of their 
way to provide comfort and support to me. It 
is compassionate, practical, and makes clear 
economic sense. Does that sound like the 
Republicans’ “death panel”?
As I cannot assure my patients a decent 
standard of medicine, I plan to leave the 
profession for a while to help the Obama 
presidency to rectify and humanise American 
medicine. I don’t know what my patients will 
do, but I think my father would appreciate this 
categorical imperative.
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the “s” word
Spence laudably defends the NHS, but it is a 
shame that he feels it necessary to claim that 
“this is not socialism.”1 The very things that 
most of us value about the NHS—its universality, 
equity, and the provision of personal good 
through public solidarity rather than private 
self interest—are the essence of socialism, and 
Spence’s own description—“all our people are 
valued and will be treated equally”—is as good a 
10 word definition of socialism as I have seen.
Ideologues in the US and elsewhere may treat 
socialism as a dirty word, but it was the source of 
the NHS, and those of us who support the results 
should at least recognise where the means 
originated. Nye Bevan and his comrades were 
proud of the NHS, and the NHS should be proud 
of them.
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